Recently Mayne Pharma set up dedicated sales teams in the US and Australia to promote its new oral contraceptive called Nextstellis. It may be beneficial to do a deal with this established marketing and distribution channel to market.
Some medical clinicians describe Nextstellis as the gold standard oral contraceptive for endo patients, like my daughter.
Cheers……D
PIQ Price at posting:
80.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)